Categories: Technology

IvoryLab fast-tracks development with support from the Telnyx AI Accelerator

AUSTIN, TX, June 19, 2025 (GLOBE NEWSWIRE) — Telnyx, a leading provider of voice, messaging, and connectivity solutions for AI-powered communications, today shared that Poland-based startup IvoryLab has significantly advanced the development of its AI voice automation platform through the Telnyx AI Accelerator. The program, which provides up to $20,000 in credits, technical enablement, and priority support, empowered the IvoryLab team to move from MVP to production-ready with speed and confidence.

IvoryLab is building a scalable voice automation platform that helps businesses handle both inbound and outbound customer calls using AI-powered voice assistants. The platform supports use cases across hospitality, real estate, health and wellness, and food delivery, with functionality ranging from customer service to outbound lead qualification.

As a small team with a big roadmap, removing cost constraints allowed IvoryLab to experiment, break things, and refine their platform without hesitation. Marcel Karpiak, co-founder of IvoryLab, shared, “The Accelerator will definitely help us to build a product which is the closest to perfection…Now we can test freely and not worry about the cost as much.”

The IvoryLab platform is built on Telnyx APIs and infrastructure, enabling rapid prototyping and seamless call orchestration. The team commented on Telny’s intuitive yet powerful developer experience—designed to support both fast iteration and long-term scalability. “We really like the Telnyx interface. Everything is super intuitive,” said Karpiak. He also noted that while other tools felt overly simplified, Telnyx struck the right balance between usability and professional-grade depth. 

IvoryLab dove head first into Telnyx AI assistants, and since joining the program, they have:

  • Created 11 AI assistants
  • Conducted 464 conversations
  •  Logged 745 minutes (12.5 hours) of conversation usage

With potential STT integrations that better support Polish, the company anticipates these figures to triple.

“The Accelerator enabled us to move from MVP to a production grade AI solution faster,” said Adrian Marcinkowski, founder of IvoryLab. The partnership with the Telnyx AI Accelerator has helped them think bigger and build more confidently.

“We designed the AI Accelerator to help teams like IvoryLab iterate quickly and get real products into users’ hands,” said Ian Reither, COO at Telnyx. “It’s been exciting to watch their progress, and we’re looking forward to seeing other emerging use cases across the Accelerator portfolio.”

IvoryLab plans to launch its platform commercially within the next few weeks, targeting subscription-based deployments across Europe.

ABOUT TELNYX

Telnyx is a global connectivity platform that provides carrier-grade voice, messaging, and real-time communication APIs to developers and enterprises. As the infrastructure layer for AI-powered communication, Telnyx helps businesses build and scale next-generation experiences—from AI voice assistants to global contact centers. Learn more at telnyx.com.



GlobeNews Wire

Recent Posts

MAGFAST Moves Christmas to July and Adds a Full Spectrum of Color to the Worlds Only Complete Charging System

HUNTINGTON BEACH, Calif., July 03, 2026 (GLOBE NEWSWIRE) -- MAGFAST, creator of a unique, integrated…

53 minutes ago

XPPen Strengthens Its Commitment to Animation with 2026 Annecy Festival Residency Partnership and MIFA Showcase

ANNECY, France, July 03, 2026 (GLOBE NEWSWIRE) -- XPPen, a global leading brand in digital…

53 minutes ago

Beyond Pet-Friendly: PureCozy Introduces a New Vision for Human-Pet Living

Denver, CO, July 03, 2026 (GLOBE NEWSWIRE) -- From DualSeason Rug™ to Furniture-Integrated Pet Spaces,…

53 minutes ago

Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program

HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink:…

55 minutes ago

Court Approval of a Restructuring Transaction Allowing Continuation of Uninterrupted Operations

MONTREAL, July 03, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health”…

55 minutes ago

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

July 03, 2026 16:30 ET  | Source: Teladoc Health, Inc. NEW YORK, July 03, 2026…

55 minutes ago